A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC) Meeting Abstract
| Authors: | Rathkopf, D. E.; Wong, B. Y.; Ross, R. W.; George, D. J.; Picus, J.; Atadja, P.; Yang, W.; Culver, K. W.; Woo, M. M.; Scher, H. I. |
| Abstract Title: | A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC) |
| Meeting Title: | 33rd ESMO Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 19 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2008 Sep 12-16 |
| Meeting Location: | Stockholm, Sweden |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2008-09-01 |
| Start Page: | viii199 |
| End Page: | viii200 |
| Language: | English |
| ACCESSION: | WOS:000259973300620 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdn510 |
| PUBMED: | 18790885 |
| Notes: | Meeting Abstract: 621P -- "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
